AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADCT
  4. [EFFECT] ADC Therapeutics SA SEC Filing

[EFFECT] ADC Therapeutics SA SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 4:00 P.M.
Form: S-3
CIK: 0001771910
Company Name: ADC Therapeutics SA
File Number: 333-288437

Source:

Stock ADCT logo
Adc Therapeutics Sa

NYSE:ADCT

ADCT Rankings

#5870 Ranked by Market Cap
N/A Ranked by Dividends

ADCT Latest News

Aug 1, 2025
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Jul 1, 2025
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
Jun 16, 2025
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
Jun 12, 2025
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
Jun 12, 2025
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress

ADCT Latest SEC Filings

Jul 10, 2025
[424B3] ADC Therapeutics SA Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 30, 2025
[S-3] ADC Therapeutics SA Shelf Registration Statement

ADCT Stock Data

330.05M
71.77M
20.64%
63.17%
5.48%
Biotechnology
Pharmaceutical Preparations
Switzerland
EPALINGES